OLK
Olink Holding AB ADR
NASDAQ: OLK · HEALTHCARE · DIAGNOSTICS & RESEARCH
$26.08
+0.00% today
Updated 2026-04-30
Market cap
$3.24B
P/E ratio
—
P/S ratio
18.98x
EPS (TTM)
$-0.27
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Olink Holding AB ADR (OLK) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Operating cash flow | $-21.02M | $-6.79M | $-53.69M | $-30.07M | $-30.04M |
| Capital expenditures | $698000.00 | $11.25M | $14.81M | $8.55M | $21.30M |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | $0.00 | $2.52M | $7.91M | $11.06M |
| Free cash flow | $-21.72M | $-18.04M | $-68.49M | $-38.62M | $-51.34M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |